LD
AVNS

Lipe & Dalton’s Avanos Medical AVNS Stock Holding History

Lipe & Dalton’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-61,820
Closed -$1.76M – 72
2015
Q3 		$1.76M Sell
61,820
-2,455
-4% -$85.6K 1.46% 27
2015
Q2 		$2.6M Sell
64,275
-825
-1% -$37K 1.87% 27
2015
Q1 		$3.2M Buy
+65,100
New +$3.02M 2.21% 27

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Lipe & Dalton's AVNS Position: Q4 2015 in Review

Lipe & Dalton sold out of Avanos Medical (AVNS) in Q4 2015, closing a stake of 61,820 shares — an estimated $1.76M sold.

Lipe & Dalton first reported a position in AVNS in Q1 2015 and held it in 3 quarters. The position peaked at $3.2M in Q1 2015. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2015.

  • Lipe & Dalton reported no remaining Avanos Medical position as of Q4 2015 after selling out during the quarter.
  • Lipe & Dalton sold 61,820 Avanos Medical shares in Q4 2015, an estimated $1.76M.
  • Lipe & Dalton first reported a position in Avanos Medical in Q1 2015 and held it in 3 quarters.
  • Lipe & Dalton's Avanos Medical position peaked at $3.2M in Q1 2015.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2015.

Based on Lipe & Dalton's 13F filing for Q4 2015, filed 10 Feb 2016.